Update search
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Journal
Type
Date
Availability
1-7 of 7
Keywords: Developing countries
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
International Journal of Pharmaceutical and Healthcare Marketing (2023) 17 (1): 132–152.
Published: 03 February 2023
... effective marketing strategies to increase the acceptability of mHealth services. 15 05 2021 05 10 2022 10 01 2023 © Emerald Publishing Limited 2023 Emerald Publishing Limited Licensed re-use rights only mHealth Adoption TAM Elderly women Developing countries Due...
Journal Articles
International Journal of Pharmaceutical and Healthcare Marketing (2023) 17 (1): 97–114.
Published: 19 December 2022
...Pross Oluka Nagitta; Marcia Mkansi Purpose Artemisinin-based combination therapies (ACTs) have been developed to treat uncomplicated malaria. However, scanty studies exist to inform the role of macro factors in explaining the nonavailability of ACT in developing countries. Therefore, this paper...
Journal Articles
International Journal of Pharmaceutical and Healthcare Marketing (2020) 14 (2): 251–272.
Published: 23 March 2020
... the continuance usage of this service. Moreover, the contextualization of the related variables and integration of the existing model is theoretically original. Furthermore, because of a generic approach, the findings could be easily modified to assist other developing countries in the planning and up-take...
Journal Articles
International Journal of Pharmaceutical and Healthcare Marketing (2018) 12 (3): 288–306.
Published: 11 July 2018
...-care services were established in the context of a developing country. Originality/value The study makes important contribution by empirically investigating the inpatient assessment of health-care service quality based upon their demographic information and repeated availing of services...
Journal Articles
International Journal of Pharmaceutical and Healthcare Marketing (2012) 6 (2): 140–155.
Published: 22 June 2012
... of pharmaceutical drugs in one developing country, Egypt. Design/methodology/approach The authors surveyed pharmacists in Cairo, Egypt. The pharmacists were asked to estimate the percentages of patients who came in with a prescription, with only a box or a recommendation for a medicine and with only symptoms...
Journal Articles
International Journal of Pharmaceutical and Healthcare Marketing (2009) 3 (4): 363–380.
Published: 20 November 2009
... of TQM studies in developing countries. Design/methodology/approach A 29‐item survey questionnaire is sent to 90 pharmaceutical distributors. Response rate is 56.7 per cent. Confirmatory factor analysis deletes one item in the scale purification process. Findings Data analysis reveal...
Journal Articles
International Journal of Pharmaceutical and Healthcare Marketing (2008) 2 (2): 103–116.
Published: 27 June 2008
... prescription drug prices in the developing as well as developed countries. Given the importance of the pharma industry to the health of nations, firms in rich and poor countries alike will continue to come under public pressure to develop and market the needed drugs at affordable prices...
